Contraception
Volume 81, Issue 3 , Pages 223-225, March 2010

Extended regimens of the contraceptive vaginal ring: evaluation of clinical aspects

  • Fernando Augusto Barreiros

      Affiliations

    • Department of Obstetrics and Gynecology, Sao Paulo Federal University Family Planning Clinic (UNIFESP), 1767 São Paulo, Brazil
    • Western Paulista University, Presidente Prudente, São Paulo, Brazil
  • ,
  • Cristina Aparecida Falbo Guazzelli

      Affiliations

    • Department of Obstetrics and Gynecology, Sao Paulo Federal University Family Planning Clinic (UNIFESP), 1767 São Paulo, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +55 11 55722605; fax: +55 11 55722605.
  • ,
  • Ricardo Barbosa

      Affiliations

    • Western Paulista University, Presidente Prudente, São Paulo, Brazil
  • ,
  • Francisco de Assis

      Affiliations

    • Western Paulista University, Presidente Prudente, São Paulo, Brazil
  • ,
  • Fábio Fernando de Araújo

      Affiliations

    • Department of Obstetrics and Gynecology, Sao Paulo Federal University Family Planning Clinic (UNIFESP), 1767 São Paulo, Brazil

Received 25 August 2009; received in revised form 30 September 2009; accepted 14 October 2009. published online 16 November 2009.

Abstract 

Background

Oral contraceptives used for extended periods of time have been extensively studied because of their potential benefits; however, there have been few publications on extended regimens of vaginal contraceptive rings. The aim of this study was to evaluate the clinical symptoms, body weight and blood pressure changes in women using the vaginal ring continuously over a 1-year period.

Study Design

This prospective cohort evaluated clinical aspects (dysmenorrhea, headache, breast tenderness, leg pain and irritability), body weight and blood pressure changes in 75 women (18–37 years of age) using a vaginal ring releasing 120 mcg of etonogestrel and 15 mcg of ethinyl estradiol daily, over a continuous period of 84 days, followed by a 7-day ring-free interval, during 1 year. The chi-square, Wilcoxon and paired t tests were used to analyze differences in the outcomes of interest.

Results

Compared to pre-enrollment status, at the end of the study period, the patients reported significantly less dysmenorrhea and irritability, a nonsignificant decrease in breast tenderness, leg pain and headaches. Blood pressure measurements remained unchanged. Although weight and body mass index increased significantly among users, they remained within the expected biological variation range.

Conclusion

The vaginal ring used on an extended regimen is a well-tolerated contraceptive method and also offers noncontraceptive benefits.

Keywords: Ring, Extended, Clinical, Contraceptive, Etonogestrel, Ethinyl estradiol

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 There was no funding for this study.

PII: S0010-7824(09)00453-3

doi:10.1016/j.contraception.2009.10.007

Contraception
Volume 81, Issue 3 , Pages 223-225, March 2010